Combined analysis from TCGA and GTEx databases indicated that LAPTM4B expression negatively correlates with overall survival expectation in both sarcoma (Fig. 1i) and pan-cancer including 33 types of cancer (Supplementary Fig. S1b). Here, LAPTM4B is linked to sarcoma.